FDA Inspection
Hahnemann Laboratories, Inc., dba Alpine PharmaceuticalsFDA Inspection 1116226 - Hahnemann Laboratories, Inc., dba Alpine Pharmaceuticals - January 28, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Hahnemann Laboratories, Inc., dba Alpine Pharmaceuticals, with an inspection on January 28, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- January 28, 2020
- Product Type
- Drugs
Open in Dashboard
ID · e74fb015-6b18-4964-8744-34db101b3ed5
Violation Codes5
21 CFR 211.165(e)21 CFR 211.22(d)21 CFR 211.25(a)21 CFR 211.84(d)(2)21 CFR 211.84(e)
Full citation text and observation details available on the Dashboard.